- Home
- WFCF vs ARTV Comparison
WFCF vs ARTV Comparison
Compare WFCF & ARTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WFCF
- ARTV
- Stock Information
- Founded
- WFCF 1996
- ARTV 2019
- Country
- WFCF United States
- ARTV United States
- Employees
- WFCF N/A
- ARTV N/A
- Industry
- WFCF Computer Software: Prepackaged Software
- ARTV
- Sector
- WFCF Technology
- ARTV
- Exchange
- WFCF Nasdaq
- ARTV NYSE
- Market Cap
- WFCF 60.7M
- ARTV 61.9M
- IPO Year
- WFCF 2011
- ARTV 2024
- Fundamental
- Price
- WFCF $10.38
- ARTV $1.95
- Analyst Decision
- WFCF
- ARTV Strong Buy
- Analyst Count
- WFCF 0
- ARTV 7
- Target Price
- WFCF N/A
- ARTV $19.17
- AVG Volume (30 Days)
- WFCF 1.6K
- ARTV 154.3K
- Earning Date
- WFCF 05-08-2025
- ARTV 05-08-2025
- Dividend Yield
- WFCF N/A
- ARTV N/A
- EPS Growth
- WFCF N/A
- ARTV N/A
- EPS
- WFCF 0.38
- ARTV N/A
- Revenue
- WFCF $25,437,000.00
- ARTV N/A
- Revenue This Year
- WFCF N/A
- ARTV N/A
- Revenue Next Year
- WFCF N/A
- ARTV N/A
- P/E Ratio
- WFCF $27.63
- ARTV N/A
- Revenue Growth
- WFCF N/A
- ARTV N/A
- 52 Week Low
- WFCF $9.26
- ARTV $1.78
- 52 Week High
- WFCF $13.50
- ARTV $17.31
- Technical
- Relative Strength Index (RSI)
- WFCF 46.95
- ARTV N/A
- Support Level
- WFCF $9.26
- ARTV N/A
- Resistance Level
- WFCF $11.26
- ARTV N/A
- Average True Range (ATR)
- WFCF 0.24
- ARTV 0.00
- MACD
- WFCF 0.01
- ARTV 0.00
- Stochastic Oscillator
- WFCF 56.15
- ARTV 0.00
About WFCF Where Food Comes From Inc.
Where Food Comes From Inc is a third-party food verification company. It offers food production audits and uses verification processes to ensure that claims made by food producers and processors are accurate. The company supports farmers, ranchers, vineyards, wineries, processors, retailers, distributors, trade associations, and restaurants with a wide variety of value-added services provided through its family of verifiers, including International Certification Services, Validus Verification Services, and others. The company operates in two segments that are verification and certification and Software Sales and Related Consulting. It generates the majority of its revenue from verification and certification.
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).